Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations

por Lipitz‐Snyderman, Allison, Chimonas, Susan, Mailankody, Sham, Kim, Michelle, Silva, Nicholas, Kriplani, Anuja, Saltz, Leonard B., Sihag, Smita, Tan, Carlyn Rose, Widmar, Maria, Zauderer, Marjorie, Weingart, Saul, Perchick, Wendy, Roman, Benjamin R.
Publicado 2023

Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma

por Tan, Carlyn Rose, Derkach, Andriy, Nemirovsky, David, Ciardiello, Amanda, Diamond, Benjamin, Hultcrantz, Malin, Hassoun, Hani, Mailankody, Sham, Shah, Urvi, Maclachlan, Kylee, Patel, Dhwani, Lahoud, Oscar, Landau, Heather, Chung, David, Shah, Gunjan, Scordo, Michael, Giralt, Sergio, Lesokhin, Alexander, Usmani, Saad, Landgren, Ola, Korde, Neha
Publicado 2023

Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma

por Tan, Carlyn Rose, Derkach, Andriy, Nemirovsky, David, Ciardiello, Amanda, Diamond, Benjamin, Hultcrantz, Malin, Hassoun, Hani, Mailankody, Sham, Shah, Urvi, Maclachlan, Kylee, Patel, Dhwani, Lahoud, Oscar B., Landau, Heather J., Chung, David J., Shah, Gunjan L., Scordo, Michael, Giralt, Sergio A., Lesokhin, Alexander, Usmani, Saad Z., Landgren, Ola, Korde, Neha
Publicado 2023